BI-187004 是一种 11β-羟基类固醇脱氢酶 1 抑制剂。

BI-187004 is an 11β-hydroxysteroid dehydrogenase 1 inhibitor.

BI-187004 was administered once daily for 14 days to eight patients with type 2 diabetes mellitus. N-methylation was identified as a major biotransformation pathway[1].

1303515-32-3

C21H18N4O

342.39

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years